Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Steve obtained an honours degree in Medicinal and Pharmaceutical Chemistry from Loughborough University before moving to Leicester University Medical School for his PhD and a postdoc studying inositide signalling under Stefan Nahorski.
Neuroscientist/Neuropharmacologist with extensive experience and expertise encompassing the pharmacology of neurotransmitters in relation to the visual and the somatosensory/pain systems, cognition and attention processes, and the functional consequences of retinal degenerations in diseases of the eye.
Tony Sampson read Natural Sciences at the University of Cambridge and gained a PhD in Pharmacology at King's College London.
Gareth Sanger uses pharmacology to solve physiological problems.
My research focuses on subcellular compartments (signalosomes) that enables cells to exert highly specialized tasks.
Richard (Rick) Schulz is a Professor in the Departments of Pediatrics and Pharmacology at the University of Alberta in Edmonton, Canada.
Matthias Schwab is professor and chair of Clinical Pharmacology, and heads the department of Clinical Pharmacology, University of Tuebingen and the Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
Retired Pharmaceutical Industry professional with over 30 years experience in Early Development Scientific Innovation, Operations and Strategy across a wide range of therapeutic areas.
Andrew Scourfield is a consultant in clinical pharmacology and general internal medicine at University College Hospital in London.